Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study

Emanuel Citgez, Job van der Palen, Kirsten Koehorst-ter Huurne, Kris Movig, Paul van der Valk, Marjolein Brusse-Keizer

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
6 Downloads (Pure)

Abstract

BACKGROUND: Both chronic inflammation and cardiovascular comorbidity play an important role in the morbidity and mortality of patients with chronic obstructive pulmonary disease (COPD). Statins could be a potential adjunct therapy. The additional effects of statins in COPD are, however, still under discussion. The aim of this study is to further investigate the association of statin use with clinical outcomes in a well-described COPD cohort.

METHODS: 795 patients of the Cohort of Mortality and Inflammation in COPD (COMIC) study were divided into statin users or not. Statin use was defined as having a statin for at least 90 consecutive days after inclusion. Outcome parameters were 3-year survival, based on all-cause mortality, time until first hospitalisation for an acute exacerbation of COPD (AECOPD) and time until first community-acquired pneumonia (CAP). A sensitivity analysis was performed without patients who started a statin 3 months or more after inclusion to exclude immortal time bias.

RESULTS: Statin use resulted in a better overall survival (corrected HR 0.70 (95% CI 0.51 to 0.96) in multivariate analysis), but in the sensitivity analysis this association disappeared. Statin use was not associated with time until first hospitalisation for an AECOPD (cHR 0.95, 95% CI 0.74 to 1.22) or time until first CAP (cHR 1.1, 95% CI 0.83 to 1.47).

CONCLUSIONS: In the COMIC study, statin use is not associated with a reduced risk of all-cause mortality, time until first hospitalisation for an AECOPD or time until first CAP in patients with COPD.
Original languageEnglish
Article numbere000142
Number of pages7
JournalBMJ open respiratory research
Volume3
Issue number1
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study'. Together they form a unique fingerprint.

Cite this